Efficacy of artesunate for treatment of cytomegalovirus reactivation post allogeneic haematopoietic stem cell transplants

被引：1
|
作者：
Gokarn, Anant [1 ,2 ]
Shenoy, Ramnath [1 ]
Punatar, Sachin [1 ,2 ]
Mirgh, Sumeet [1 ,2 ]
Chichra, Akanksha [1 ,2 ]
Nayak, Lingaraj [1 ,2 ]
Bonda, Avinash [1 ,2 ]
Jindal, Nishant [1 ,2 ]
Saroha, Megha [1 ]
Toshniwal, Anup [1 ]
Prayag, Parikshit [3 ]
Tripathi, Rachana [4 ]
Kumar, Shesheer [4 ]
Bhat, Vivek [2 ,5 ]
Biswas, Sanjay [2 ,5 ]
Khattry, Navin [1 ,2 ]
机构：
[1] Tata Mem Hosp, Dept Med Oncol, Mumbai, India
[2] Homi Bhabha Natl Inst, Mumbai, India
[3] Deenanath Mangeshkar Hosp, Res Ctr, Infect Dis, Pune, India
[4] Huwel Lifesci Pvt Ltd, Hyderabad, India
[5] Tata Mem Hosp, Dept MicroBiol, Mumbai, India
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / 02期
关键词：
REPLICATION;
D O I：
10.1038/s41409-022-01850-z
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：209 / 211
页数：3
相关论文
共 50 条
  • [41] Cytomegalovirus infection in children after allogeneic haematopoietic stem cell transplantation in a developing country
    Hazar, V.
    Uygun, V.
    Karasu, G.
    Eker, N.
    Tayfun, F.
    Kupesiz, A.
    Yesilipek, A.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S332 - S332
  • [42] Pre-emptive treatment with rituximab for Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation: a safety and efficacy study
    Ganguly, S.
    DuBois, L.
    Divine, C.
    Aljitawi, O.
    Abhyankar, S.
    McGuirk, J.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S225 - S225
  • [43] Is cytomegalovirus a risk factor for haemorrhagic cystitis in allogeneic haematopoietic stem cell transplantation recipients?
    Atilla, Erden
    Yalciner, Merih
    Ailla, Pinar Ataca
    Ates, Can
    Bozdag, Sinem Civriz
    Yuksel, Meltem Kurt
    Toprak, Selami Kocak
    Gunduz, Mehmet
    Ozen, Mehmet
    Akan, Hamdi
    Demirer, Taner
    Arslan, Onder
    Ilhan, Osman
    Beksac, Meral
    Ozcan, Muhit
    Gurman, Gunhan
    Topcuoglu, Pervin
    ANTIVIRAL THERAPY, 2018, 23 (08) : 647 - 653
  • [44] Efficacy and toxicity of ganciclovir and foscarnet combination therapy for refractory Cytomegalovirus reactivation in adult allogeneic stem cell transplant recipients
    Kohlschmidt, Melanie
    Christopeit, Maximilian
    Wolschke, Christine
    Ayuk, Francis
    Kroger, Nicolaus
    Langebrake, Claudia
    BONE MARROW TRANSPLANTATION, 2018, 53 : 555 - 556
  • [45] HLA-A*02 molecule associates with a risk of EBV and CMV reactivation in patients post allogeneic haematopoietic stem cell transplantation
    Jaskula, E.
    Polak, M.
    Koscinska, K.
    Bogunia-Kubik, K.
    Turlej, E.
    Lange, A.
    TISSUE ANTIGENS, 2008, 71 (04): : 323 - 323
  • [46] Haematopoietic stem cell transplants: principles and indications
    Balassa, Katalin
    Danby, Robert
    Rocha, Vanderson
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2019, 80 (01) : 33 - 39
  • [47] Monitoring of cytomegalovirus-specific immune recovery in recipients of allogeneic stem cell transplants
    Lysák, D
    Steinerová, K
    Jindra, P
    Koza, V
    BONE MARROW TRANSPLANTATION, 2006, 37 : S172 - S172
  • [48] The association of conditioning regimen with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
    Mardani, Masoud
    Abolghasemi, Sara
    Shabani, Shiva
    Tavakoli, Farzaneh
    Saeedi, Anahita
    Parkhideh, Sayeh
    Hajifathali, Abbas
    IRANIAN JOURNAL OF MICROBIOLOGY, 2020, 12 (06) : 636 - 643
  • [49] The Impact of Letermovir Prescribing on the Rate of Cytomegalovirus Reactivation Following Allogeneic Stem Cell Transplantation
    Smith, Siobhan
    Duncan, Nick
    Ricketts, Laura
    O'Neill, Jessica
    Gautama, Brijesh
    Ibrahim, Abeer
    Jones, Ceri H.
    Kempshall, Emma
    Ingram, Wendy
    Wilson, Keith
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 372 - 373
  • [50] Monitoring of cytomegalovirus-specific imniune recovery in recipients of allogeneic stem cell transplants
    Lysak, D.
    Steinerova, K.
    Jindra, P.
    Koza, V.
    CYTOTHERAPY, 2006, 8
12345